CJC-1295 NO DAC 10mg

Molecular Composition of CJC-1295 No DAC

CJC-1295 No DAC is a synthetic peptide recognized for its role as a growth hormone-releasing hormone (GHRH) analog. The molecular composition of this peptide involves a specific amino acid sequence that plays a crucial role in its biological activity. The structure consists of 30 amino acids, which are core to its functionality, allowing it to stimulate the release of growth hormone from the pituitary gland. The exact sequence of CJC-1295 No DAC is: Tyr-Ser-Lys-Arg-Pro-Gly-Gln-Ser-Arg-Lys-Leu-Met-Arg-Ser-Arg-Phe-Ala-Ser-Gly-Thr-Ser-Asp-Phe-Phe-His-Gln-Arg-His-Leu-Asp-Arg-Gly, reflecting the critical placements of residues that contribute to its pharmacological characteristics.

Additionally, the structural details of CJC-1295 No DAC reveal that it has a unique configuration that enhances its binding affinity to growth hormone receptors. This structural optimization is essential for the increased half-life of the peptide compared to its precursors. The absence of a drug affinity complex (DAC) in CJC-1295 No DAC indicates that it relies solely on its intrinsic properties to promote growth hormone secretion, thereby offering a more streamlined and targeted action.

One of the standout features of CJC-1295 No DAC is its impressive 99% purity. This high purity level is critical for ensuring reliable results in scientific investigations. When utilized in research applications, the consistency and reliability of peptides with such purity yield accurate and reproducible data. The molecular interactions fostered by the peptide, including its stability and effectiveness, are greatly enhanced by this purification level, making it a highly sought-after compound for investigative purposes. The study of CJC-1295 No DAC thus not only explores its molecular structure but also paves the way for advancements in peptide research and potential therapeutic applications.